Search research articles
Contact Us
Filters
Showing results (461-470 of 928) with videos related to
Page
of 93
Sort By:
Journal of the American Heart Association
|
September 30, 2025
Acute Valve Syndrome Before Aortic Valve Replacement: Impact on Clinical Outcomes, Health Care Costs, and Resource Use
Philippe Généreux, Gennaro Giustino, Brian R Lindman, et al.
Science Translational Medicine
|
September 13, 2019
Ventricular stroke work and vascular impedance refine the characterization of patients with aortic stenosis
Eyal Ben-Assa, Jonathan Brown, Zahra Keshavarz-Motamed, et al.
Journal of the American College of Cardiology
|
July 21, 2004
Frequency, correlates, and clinical implications of myocardial perfusion after primary angioplasty and stenting, with and without glycoprotein IIb/IIIa inhibition, in acute myocardial infarction
Costantino O Costantini, Gregg W Stone, Roxana Mehran, et al.
JACC. Cardiovascular Interventions
|
February 5, 2010
Late safety, efficacy, and cost-effectiveness of a zotarolimus-eluting stent compared with a paclitaxel-eluting stent in patients with de novo coronary lesions: 2-year follow-up from the ENDEAVOR IV trial (Randomized, Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Taxus Paclitaxel-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions)
Martin B Leon, David E Kandzari, Eric L Eisenstein, et al.
The New England Journal of Medicine
|
February 14, 2007
Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents
Gregg W Stone, Jeffrey W Moses, Stephen G Ellis, et al.
The American Journal of Cardiology
|
May 13, 2015
Relation of frailty to outcomes after transcatheter aortic valve replacement (from the PARTNER trial)
Philip Green, Suzanne V Arnold, David J Cohen, et al.
Journal of the American College of Cardiology
|
March 19, 2004
First human experience with the 17-beta-estradiol-eluting stent: the Estrogen And Stents To Eliminate Restenosis (EASTER) trial
Alexandre Abizaid, Mariano Albertal, Marco A Costa, et al.
European Heart Journal. Cardiovascular Imaging
|
August 28, 2020
Incremental value of left ventricular global longitudinal strain in a newly proposed staging classification based on cardiac damage in patients with severe aortic stenosis
E Mara Vollema, Mohammed R Amanullah, Edgard A Prihadi, et al.
Journal of the American College of Cardiology
|
June 1, 2019
3-Year Outcomes After Valve-in-Valve Transcatheter Aortic Valve Replacement for Degenerated Bioprostheses: The PARTNER 2 Registry
John G Webb, Dale J Murdoch, Maria C Alu, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography
|
October 2, 2018
Comparison between Three-Dimensional Echocardiography and Computed Tomography for Comprehensive Tricuspid Annulus and Valve Assessment in Severe Tricuspid Regurgitation: Implications for Tricuspid Regurgitation Grading and Transcatheter Therapies
Fabien Praz, Omar K Khalique, Leon G Dos Reis Macedo, et al.
Page
of 93
Search research articles
Search
Showing results (461-470 of 928) with videos related to
Sort By:
Page
of 93
Journal of the American Heart Association
|
September 30, 2025
Acute Valve Syndrome Before Aortic Valve Replacement: Impact on Clinical Outcomes, Health Care Costs, and Resource Use
Philippe Généreux, Gennaro Giustino, Brian R Lindman, et al.
Science Translational Medicine
|
September 13, 2019
Ventricular stroke work and vascular impedance refine the characterization of patients with aortic stenosis
Eyal Ben-Assa, Jonathan Brown, Zahra Keshavarz-Motamed, et al.
Journal of the American College of Cardiology
|
July 21, 2004
Frequency, correlates, and clinical implications of myocardial perfusion after primary angioplasty and stenting, with and without glycoprotein IIb/IIIa inhibition, in acute myocardial infarction
Costantino O Costantini, Gregg W Stone, Roxana Mehran, et al.
JACC. Cardiovascular Interventions
|
February 5, 2010
Late safety, efficacy, and cost-effectiveness of a zotarolimus-eluting stent compared with a paclitaxel-eluting stent in patients with de novo coronary lesions: 2-year follow-up from the ENDEAVOR IV trial (Randomized, Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Taxus Paclitaxel-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions)
Martin B Leon, David E Kandzari, Eric L Eisenstein, et al.
The New England Journal of Medicine
|
February 14, 2007
Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents
Gregg W Stone, Jeffrey W Moses, Stephen G Ellis, et al.
The American Journal of Cardiology
|
May 13, 2015
Relation of frailty to outcomes after transcatheter aortic valve replacement (from the PARTNER trial)
Philip Green, Suzanne V Arnold, David J Cohen, et al.
Journal of the American College of Cardiology
|
March 19, 2004
First human experience with the 17-beta-estradiol-eluting stent: the Estrogen And Stents To Eliminate Restenosis (EASTER) trial
Alexandre Abizaid, Mariano Albertal, Marco A Costa, et al.
European Heart Journal. Cardiovascular Imaging
|
August 28, 2020
Incremental value of left ventricular global longitudinal strain in a newly proposed staging classification based on cardiac damage in patients with severe aortic stenosis
E Mara Vollema, Mohammed R Amanullah, Edgard A Prihadi, et al.
Journal of the American College of Cardiology
|
June 1, 2019
3-Year Outcomes After Valve-in-Valve Transcatheter Aortic Valve Replacement for Degenerated Bioprostheses: The PARTNER 2 Registry
John G Webb, Dale J Murdoch, Maria C Alu, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography
|
October 2, 2018
Comparison between Three-Dimensional Echocardiography and Computed Tomography for Comprehensive Tricuspid Annulus and Valve Assessment in Severe Tricuspid Regurgitation: Implications for Tricuspid Regurgitation Grading and Transcatheter Therapies
Fabien Praz, Omar K Khalique, Leon G Dos Reis Macedo, et al.
Page
of 93